To dis­close CME pay­ments or not to dis­close, that is the ques­tion

Modern Healthcare - - THE WEEK AHEAD - —Jaimy Lee

Physi­cians and in­dus­try groups have un­til Sept. 2 to make their case that drug- and de­vice-com­pany pay­ments made through ac­cred­ited con­tin­u­ing med­i­cal ed­u­ca­tion pro­grams should not be pub­licly re­ported un­der the Physi­cian Pay­ments Sun­shine Act.

In a sur­prise move, the CMS in July pro­posed re­mov­ing the re­port­ing ex­emp­tion for ac­cred­ited CME pay- ments. Its rule would re­quire that any pay­ments or trans­fers of value made to physi­cians who par­tic­i­pate in ac­cred­ited CME pro­grams be dis­closed through the Open Pay­ments web­site. As of Aug. 27, the CMS had re­ceived more than 400 public com­ments re­lated to the CME is­sue, said An­drew Rosen­berg, se­nior ad­viser for the CME Coali­tion, which lob­bies for CME providers.

Dis­clos­ing CME pay­ments “could dis­cour­age physi­cians from par­tic­i­pat­ing as fac­ulty or learn­ers and re­sult in sig­nif­i­cant neg­a­tive out­comes for pa­tients,” wrote Dr. Barry Make, a pro­fes­sor at Na­tional Jewish Health in Den­ver.

The Sun­shine Act pro­vi­sion of the Pa­tient Pro­tec­tion and Af­ford­able Care Act re­quires drug and de­vice man­u­fac­tur­ers to re­port di­rect pay­ments or trans­fers of value they make to physi­cians and teach­ing hos­pi­tals. The CMS is sched­uled to re­lease the first pay­ment data to the public in Septem­ber. It is de­lay­ing re­lease of about one-third of the data be­cause of what it says are in­ac­cu­ra­cies. Drug­mak­ers are ques­tion­ing the de­ci­sion to with­hold that data.

The Amer­i­can Med­i­cal As­so­ci­a­tion and the CME Coali­tion are ex­pected to file com­ments by the Sept. 2 dead­line. Both groups have urged a de­lay in the re­lease of Sun­shine Act data.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.